Allarity Therapeutics Inc (NASDAQ:ALLR) currently has a daily average trading volume of 1.51M but it saw 2336997 shares traded in last market. With a market cap of 5.23M USD, the company’s current market price of $1.18 came falling about -16.31 while comparing to the previous closing price of $1.41. In past 52 weeks, the stock remained buoying in the range of price level as high as $288.00 and as low as $0.90. In the recent trading on the day, stock has struck highest price mark of $1.12 while lowest mark touched by it was $1.41.
Taking a look at 20-day trading activity of Allarity Therapeutics Inc (ALLR) gives us an average price of $1.1470, while its current price level is -99.59% below from 52-week high level whereas it is 31.11% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1237 while that of 200 days or SMA-200 reads an average of $8.4212. A closer look into the stock’s movement over the week reveals that its volatility is standing at 26.62% during that period while stretching the period over a month that decreases to 19.87%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.98 which implies that the stock is in neutral territory.
Over the week, ALLR’s stock price is moving -10.61% down while it is 9.26% when we observe its performance for the past one month. Year-to-date it is 0.85% up and over the past year, the stock is showing a downside performance of -99.53%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Allarity Therapeutics Inc’s total number of outstanding shares is 4.43M with 12.32% of that held by the insiders while 2.21% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -151.54% and return on equity (ROE) at -391.95%. Stock’s beta reads 0.30. Stock has a price to book (P/B) ratio of 0.25. Its return on asset (ROA) is -109.68% on average.
